Cite
APA Citation
George, D. J., Halabi, S., Healy, P., Barak, I., Winters, C., Anand, M., Wilder, R., Klein, M., Martinez, E., Nixon, A. B., Harrison, M. R., Szmulewitz, R., & Armstrong, A. J. (2019). phase 1b trial of docetaxel, prednisone, and pazopanib in men with metastatic castration‐resistant prostate cancer. Prostate, 79(15), 1752–1761. http://access.bl.uk/ark:/81055/vdc_100092543865.0x00005e